Olivier Hermine
Overview
Explore the profile of Olivier Hermine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
713
Citations
18673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peltier S, Marin M, Dzieciatkowska M, Dussiot M, Roy M, Bruce J, et al.
J Clin Invest
. 2025 Mar;
PMID: 40067362
Although refrigerated storage slows the metabolism of volunteer donor RBCs, which is essential in transfusion medicine, cellular aging still occurs throughout this in vitro process. Storage-induced microerythrocytes (SMEs) are morphologically-altered...
2.
Andrieu G, Simonin M, Cabannes-Hamy A, Lengline E, Marcais A, Theron A, et al.
Nat Commun
. 2025 Mar;
16(1):2191.
PMID: 40038309
The deregulated activation of the phosphoinositide 3-kinase (PI3K) pathway is a hallmark of aggressive tumors with metabolic plasticity, eliciting their adaptation to the microenvironment and resistance to chemotherapy. A significant...
3.
Bal E, Park H, Belaid-Choucair Z, Kayserili H, Naville M, Madrange M, et al.
Nat Med
. 2025 Feb;
PMID: 39915680
No abstract available.
4.
Arlet J, Bernaudin F, Deme-Ly I, Coulibaly B, Corbasson A, Diagne I, et al.
Ann Hematol
. 2025 Feb;
PMID: 39909904
The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in...
5.
Ballul T, Sabato V, Valent P, Hermine O, Lortholary O, Rossignol J
EClinicalMedicine
. 2025 Jan;
80:103043.
PMID: 39877259
Background: Systemic mastocytosis (SM) diagnosis requires the presence of 3 minor criteria or 1 major and 1 minor criterion according to the WHO 2016 classification. The aim of this study...
6.
Marouf A, Chaubard S, Lievin R, Michot J, Molinari N, Rossignol J, et al.
Hemasphere
. 2025 Jan;
9(1):e70081.
PMID: 39840381
No abstract available.
7.
Rufer A, Nilius H, Hermine O, Niedoszytko M, Oude Elberink J, Bonadonna P, et al.
Leukemia
. 2025 Jan;
39(3):675-683.
PMID: 39815050
Expression of CD2, CD25 and/or CD30 in extracutaneous mast cells (MC) is a minor diagnostic criterion for systemic mastocytosis (SM) in the classification of the World Health Organization and International...
8.
Guedon A, Ouafdi A, Belfeki N, Dellal A, Ghriss N, Scheen M, et al.
RMD Open
. 2024 Dec;
10(4.
PMID: 39658053
Objective: We aimed to assess the prevalence of clonal haematopoiesis (CH) in patients with giant cell arteritis (GCA) compared with controls and individuals with other autoimmune diseases (AIDs) and to...
9.
Debureaux P, Poulain S, Harel S, Passet M, Temple M, Friedrich C, et al.
Blood
. 2024 Nov;
145(4):450-454.
PMID: 39571148
Inflammatory form of Waldenström macroglobulinemia (iWM) predicts outcomes after immuno-chemotherapy and Bruton tyrosine kinase inhibitors, but its origin is unknown. Here, we unravel increased clonal hematopoiesis in patients with iWM...
10.
Jiang L, Dreyling M, Hermine O, Mansmann U, Walewski J, Ribrag V, et al.
Br J Haematol
. 2024 Oct;
206(1):159-166.
PMID: 39442921
During a fatal disease, patients often request updated information on their prognosis. After patients have already survived a certain time, conditional survival captures their future survival probability. We investigated conditional...